Cigna Group (NYSE:CI – Get Free Report) insider Everett Neville sold 617 shares of the company’s stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the transaction, the insider owned 5,053 shares of the company’s stock, valued at $1,435,304.65. The trade was a 10.88% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Cigna Group Stock Down 2.3%
CI opened at $276.12 on Wednesday. The company has a market capitalization of $72.96 billion, a P/E ratio of 11.42, a P/E/G ratio of 0.97 and a beta of 0.31. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. The firm’s fifty day moving average price is $283.56 and its two-hundred day moving average price is $280.84. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $315.47.
Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company had revenue of $70.04 billion during the quarter, compared to analysts’ expectations of $70.14 billion. During the same quarter in the prior year, the company posted $7.20 EPS. The business’s revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, analysts anticipate that Cigna Group will post 30.51 EPS for the current year.
Cigna Group Dividend Announcement
Analysts Set New Price Targets
A number of equities analysts have recently issued reports on CI shares. Guggenheim increased their target price on Cigna Group from $338.00 to $361.00 and gave the stock a “buy” rating in a report on Friday, July 31st. Wells Fargo & Company lifted their price objective on Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. Deutsche Bank Aktiengesellschaft lowered shares of Cigna Group from a “buy” rating to a “hold” rating and lowered their target price for the stock from $303.00 to $302.00 in a report on Wednesday, May 20th. Sanford C. Bernstein upped their price objective on shares of Cigna Group from $371.00 to $381.00 and gave the stock an “outperform” rating in a research note on Thursday, July 9th. Finally, UBS Group raised their price objective on shares of Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a report on Friday, May 22nd. Fifteen research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $339.45.
Read Our Latest Research Report on CI
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in the business. California State Teachers Retirement System raised its stake in shares of Cigna Group by 26,190.2% in the second quarter. California State Teachers Retirement System now owns 106,647,359 shares of the health services provider’s stock worth $29,400,544,000 after acquiring an additional 106,241,705 shares during the last quarter. BlackRock Inc. increased its holdings in shares of Cigna Group by 3.7% in the second quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock valued at $6,461,457,000 after purchasing an additional 840,098 shares in the last quarter. State Street Corp increased its holdings in shares of Cigna Group by 1.8% in the fourth quarter. State Street Corp now owns 12,339,250 shares of the health services provider’s stock valued at $3,396,132,000 after purchasing an additional 224,122 shares in the last quarter. Dodge & Cox raised its position in Cigna Group by 19.7% in the 4th quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock worth $3,065,681,000 after purchasing an additional 1,833,389 shares during the last quarter. Finally, GQG Partners LLC boosted its position in Cigna Group by 14.3% in the 4th quarter. GQG Partners LLC now owns 7,763,295 shares of the health services provider’s stock valued at $2,136,699,000 after buying an additional 972,302 shares during the last quarter. 86.99% of the stock is owned by institutional investors.
Cigna Group Company Profile
The Cigna Group (NYSE: CI) is a global health services company that helps individuals, employers, health plans and government organizations access health care and related services. The company operates primarily through two businesses: Cigna Healthcare, which provides medical, behavioral health, dental and other health benefit products and services, and Evernorth Health Services, which offers pharmacy, care delivery and health benefits solutions.
Evernorth includes Express Scripts, a pharmacy benefit services provider that manages prescription drug benefits and operates home delivery and specialty pharmacy services.
Featured Stories
- Five stocks we like better than Cigna Group
- Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
- Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock
- Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement
- Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
